The largest database of trusted experimental protocols

8 protocols using ifnγ v450

1

Characterization of NK Cell Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
To assess proliferation and further characterisation of the differentiation of NK cells, PBMC were permeabilised and stained with anti-Ki67-PE (eBioscience, Hatfield, UK), Granzyme-B-FITC and Perforin-Cy5.5/PerCP (Biolegend, London, UK) directly ex-vivo. For intracellular staining for IFNγ production; PBMC were incubated with rhIL12 and rhIL15 (10ng/ml) (R&D systems, Abingdon, UK), for 19 hours at 37°C. 1mM monensin (Sigma-Aldrich, Gillingham, UK) was added for the final 3 hours. Cells were then stained with anti-CD3-Cy5.5/PerCP or CD3/Pe-Cy7, CD16-APCy7, CD56-FITC, and subsequently fixed and permeabilised, followed by intracellular staining for IFNγ-v450 (BD Biosciences, Oxford, UK). Dead cells were excluded by fixable live dead stain.
For degranulation, PBMCs were incubated with K562 cells (5:1 E:T ratio) for 3 hours following overnight stimulation with a combination of 50ng/ml rhIL12 and rhIL18 (Miltenyi Biotech). Anti-CD107a-PE mAb (BD Biociences, Oxford, UK) was added at the time of stimulation with target-cells and monensin (1mM) added during the last 2 hours of incubation prior to staining and acquisition.
+ Open protocol
+ Expand
2

Multiparameter Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
For surface staining, cells were stained with surface markers for 30
min on ice and washed twice with FACS buffer (PBS with 2% FBS and 2
mM EDTA buffer). After, cells were fixed and permeabilized with Fix/Perm
buffer (BD Biosciences) for 20 min on ice, washed twice with BD Perm/Wash,
and stained with the intracellular antibodies for 60 min on ice. For PoxP3
staining, cells were fixed and permeabilized with Fix/Perm Buffer
(eBiosciences, San Diego, CA, USA) for 60 min on ice, washed twice with
Perm/Wash buffer (eBiosciences) and stained with intracellular antibodies
for 60 min on ice. Subsequently, the cells were washed twice with the
respective Perm/Wash buffer and kept in 2% paraformaldehyde.
Antibodies used: PBS57-CD1d tet APC (kindly donated by NIH tetramer resource
facility), Vα24 FITC, and CD3 ECD were from Beckman Coulter
(Fullerton, CA), CD4 Qdot655, CD8 Qdot 605, and the viability marker AmCyan
were from Life Technologies (Carlsbad CA, USA), CD25 APC, CD38 PE, HLA-DR
PerCP, IFNγ V450, TNF Alexa700, IL-10 PE, and IL-4 PE-Cy7 were all
from BD bioscience. Data were acquired on a BD LSRFortessa instrument (BD
Biosciences) and analyzed using FlowJo Version 9.8.5 software (TreeStar,
Ashland, OR, USA).
+ Open protocol
+ Expand
3

Cytokine Production in PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
For intracellular staining for IFN-γ production, PBMCs were incubated with 50 ng/ml of rhIL-12 (Miltenyi Biotec) and 50 ng/ml of rh-IL18 (R&D Systems) for 21 h at 37°C. One mM monensin (Sigma-Aldrich, Gillingham, UK) was added for the final 3 h. Cells were stained with antibodies to CD3-PE-Cy7 (eBioscience), CD16-APC-Cy7 (BD Biosciences) and CD56-ECD (Beckman Coulter) and subsequently fixed and permeabilized, followed by intracellular staining for IFN-γ-V450 (BD Biosciences). Dead cells were excluded by live/dead stain (Invitrogen).
For TNF-α production, PBMCs were stimulated with phorbol myristate acetate (PMA) (3 ng/ml) and ionomycin (100 ng/ml) (Sigma-Aldrich) for 3 h in the presence of 1 mM of monensin (Sigma-Aldrich). Cells were stained with antibodies to CD3-PE-Cy7 (eBioscience), CD16-APC-Cy7 (BD Biosciences) and CD56-ECD (Beckman Coulter) in the presence of live/dead stain followed by fixing, permeabilization and intracellular staining for TNF-α-FITC (BD Biosciences).
+ Open protocol
+ Expand
4

Modulating T Cell Activation in CLL

Check if the same lab product or an alternative is used in the 5 most similar protocols
T cells were magnetically purified from PBMC using a PAN T-cell isolation kit (Miltenyi Biotec) from healthy donors. Healthy donor T cells (1 × 105) were then cultured with bead-purified (Miltenyi Biotec) CD19+ B cells from CLL patients (1 × 106) at an optimal 1:10 ratio per well in the presence or absence of CXCL12 (250 ng/ml), lenalidomide (10 µM), CXCR4, or mouse anti-human IL-10 blocking antibodies (2 µg/ml, R&D). Each experiment was performed in duplicate. After 48 h of culture, T cells were magnetically purified again as described above (purity >95%) and activated with anti-CD3/CD28 magnetic Dynabeads (Invitrogen) for 6 h. A negative control (no stimulation) was included in every experiment. Brefeldin A (10 µg/mL) and CD107a PE-CF594 (BD Biosciences) were added to the culture. Cells were stained with a Live/Dead-Aqua (Invitrogen), CD3-BV650, CD8-FITC, CD4-APC-Cy7, fixed/permeabilized (BD Biosciences) followed by intracellular staining with IFN-γ-V450, TNF-α-Alexa 700, and IL-2-PE (BD Biosciences).
+ Open protocol
+ Expand
5

Phenotyping Antigen-specific T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
108/ml of electroporated T cells were stained with 1 μM of CFSE (ThermoFisher #C34554) for 5mins in the dark before being washed in HBSS supplemented in 2% FBS. 2 μg/ml of Brefeldin A, CFSE engineered T cells, and HepG2.2.15 were spiked into whole blood. The spiked blood was next incubated at 37°C and at eight revolutions per minute for 16 hours using the Amersham biosciences hybridisation oven/shaker. Red blood cells were then lysed with Red Blood Cell Lysis solution (Miltenyi Biotec), and remaining cells were stained with LIVE/DEAD™ Fixable Yellow Dead Cell Stain (ThermoFisher #L34968) before being blocked with Human TruStain FcX™ (Biolegend #422301) and stained with CD3 PerCP-Cy5.5 (BD Biosciences #340949), CD8 Pe-Cy7 (BD Biosciences #557746) antibodies. Cells were then fixed and permeabilised using Cytofix/Cytoperm™ Fixation and Permeabilisation Solution (BD) before being stained with IFNγ V450 (BD Biosciences #560371), TNFα APC (BD Biosciences #554514) antibodies.
+ Open protocol
+ Expand
6

T Cell Cytokine Production Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
For cytokine production analysis by T cell subsets, surface staining was first performed with CD45-PERCP, CD3-FITC, and CD8-APC-H7 antibodies (BD Biosciences). Samples were then lysed, fixed, permeabilized, and then stained with IL-17A-eFluor660 (eBiosciences), IFNγ-V450, or IL-5-APC or IL-21-PE (BD Biosciences) antibodies. Samples were analyzed by flow cytometry.
+ Open protocol
+ Expand
7

Multiparametric Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Following incubation, EDTA (Hoefer) was added at 20 mM to arrest stimulation. Cells were surface stained with LIVE/DEAD Fixable Yellow Stain (Life Technologies), fixed and permeabilized with FACS Lysing Solution and FACS Permeabilizing Solution II (BD Biosciences), and stained with the following intracellular antibodies: CD3-PE (UCHT1, Biolegend), TNF-FITC (MAb11, BD Biosciences), IFNγ-V450 (B27, BD Biosciences), CD16-PerCP Cy5.5 (3G8, Biolegend). For degranulation, cytokine production, and ADCC experiments, cells were also surface stained with CD56-PE-Cy7 (B159, BD Biosciences). For cytotoxicity experiments, no additional antibodies were added. Stained cells were analyzed on the MACSQuant Analyzer (Miltenyi Biotec). Analysis and compensation were performed using FlowJo (FlowJo, LLC).
+ Open protocol
+ Expand
8

Multiparameter Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
For surface staining, cells were stained with surface markers for 30
min on ice and washed twice with FACS buffer (PBS with 2% FBS and 2
mM EDTA buffer). After, cells were fixed and permeabilized with Fix/Perm
buffer (BD Biosciences) for 20 min on ice, washed twice with BD Perm/Wash,
and stained with the intracellular antibodies for 60 min on ice. For PoxP3
staining, cells were fixed and permeabilized with Fix/Perm Buffer
(eBiosciences, San Diego, CA, USA) for 60 min on ice, washed twice with
Perm/Wash buffer (eBiosciences) and stained with intracellular antibodies
for 60 min on ice. Subsequently, the cells were washed twice with the
respective Perm/Wash buffer and kept in 2% paraformaldehyde.
Antibodies used: PBS57-CD1d tet APC (kindly donated by NIH tetramer resource
facility), Vα24 FITC, and CD3 ECD were from Beckman Coulter
(Fullerton, CA), CD4 Qdot655, CD8 Qdot 605, and the viability marker AmCyan
were from Life Technologies (Carlsbad CA, USA), CD25 APC, CD38 PE, HLA-DR
PerCP, IFNγ V450, TNF Alexa700, IL-10 PE, and IL-4 PE-Cy7 were all
from BD bioscience. Data were acquired on a BD LSRFortessa instrument (BD
Biosciences) and analyzed using FlowJo Version 9.8.5 software (TreeStar,
Ashland, OR, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!